(Q42439639)

English

New EGF-R selective tyrosine kinase inhibitor reveals variable growth responses in prostate carcinoma cell lines PC-3 and DU-145.

scientific article published on June 1997

Statements

New EGF-R selective tyrosine kinase inhibitor reveals variable growth responses in prostate carcinoma cell lines PC-3 and DU-145. (English)
H E Jones
C M Dutkowski
D Barrow
M E Harper
A E Wakeling
R I Nicholson
1010-1018

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit